Unknown PHASE1 INTERVENTIONAL NCT00002887

Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

PHASE I TRIAL OF HYDROXYUREA FOR SALVAGE OF INCURABLE NON-SMALL CELL LUNG CANCER

Sponsor: Ottawa Regional Cancer Centre

Interventions cisplatin drug resistance inhibition treatment etoposide hydroxyurea vinblastine sulfate vindesine vinorelbine tartrate

Updated 5 times since 2017 Last updated: Sep 16, 2013 Started: Jul 31, 1995

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Lung Cancer, this trial is ongoing. The trial is conducted by Ottawa Regional Cancer Centre and has accumulated 5 data snapshots since 1995. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jul 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ottawa Regional Cancer Centre

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottawa, Canada